PBLSParabilis Medicines, Inc.vs its industry peers
A metric-by-metric comparison of Parabilis Medicines, Inc. against SIC 2834 — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| Empresa | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| PBLSEsta | $3.6B#5 | — | 3.4x#5 | — | — | — | — | 0.0%#3 | — | — | — | — |
| ARQT | $4.1B#1 | 146.6x#3 | 18.4x#12 | 10.8x#3 | 91.3%#3 | 88.5%#1 | -3.3%#3 | -7.3%#5 | -4.1%#3 | — | 30.3%#4 | — |
| ABCL | $3.8B#2 | — | 4.2x#7 | 50.0x#5 | 160.6%#2 | 10.1%#5 | -289.0%#5 | -16.3%#8 | -28.0%#4 | — | 128.6%#1 | — |
| XENE | $3.8B#3 | — | 3.0x#3 | 500.3x#6 | — | -47.6%#8 | -4974.3%#6 | -27.8%#9 | -32.5%#5 | — | -5.7%#7 | — |
| OGN | $3.6B#4 | 17.8x#2 | 3.0x#4 | 0.6x#1 | -2.9%#5 | -78.4%#9 | 14.9%#1 | 15.7%#2 | 4.9%#2 | 5#1 | 111.7%#3 | 2.4%#1 |
| ACAD | $3.6B#6 | 9.3x#1 | 2.7x#1 | 3.3x#2 | 11.9%#4 | 73.0%#2 | 9.8%#2 | 29.9%#1 | 11.4%#1 | — | -7.3%#8 | — |
| VKTX | $3.4B#7 | — | 5.8x#10 | — | — | -227.1%#11 | — | -61.1%#12 | — | — | -26.0%#10 | — |
| DYN | $3.4B#8 | — | 4.8x#8 | — | — | -40.6%#7 | — | -0.0%#4 | -1301.5%#7 | — | -25.0%#9 | — |
| ELVN | $3.3B#9 | — | 3.7x#6 | — | — | -16.5%#6 | — | -11.6%#7 | — | — | 126.2%#2 | — |
| AMLX | $3.3B#10 | — | 13.7x#11 | — | -100.0%#6 | 52.0%#4 | — | -60.5%#11 | — | — | — | — |
| IRON | $3.1B#11 | — | 4.8x#9 | — | — | -94.0%#10 | — | -32.9%#10 | -39.0%#6 | — | -4.0%#6 | — |
| IDYA | $3.1B#12 | — | 2.8x#2 | 14.0x#4 | 3024.4%#1 | 58.6%#3 | -72.8%#4 | -10.4%#6 | — | — | 1.2%#5 | — |
Peer set: US filers sharing this company's SEC industry classification (SIC 2834). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Some peers are still being computed, so this table covers part of the group and ranks are within the rows shown; it fills in shortly. Esta tabla agotó el tiempo durante su construcción, por lo que cubre parte del grupo; los rangos son solo dentro de las filas mostradas y se completará en breve. Table built 2026-11-04.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice